Medicaid GLP-1 coverage in Rhode Island, 2026.

Rhode Island Medicaid covers Wegovy for weight loss, with limits.

Coming change. From October 1, 2026, Rhode Island Medicaid stops covering certain GLP-1s prescribed only for weight loss. Rhode Island Executive Office of Health and Human Services, FY27 Budget Initiatives, GLP-1 Benefit Change

Rhode Island last reviewed its drug list on July 1, 2026.

Coverage summary

IndicationCoverage
Wegovy (weight loss)Limited
Zepbound (weight loss)Limited
Ozempic or Mounjaro (type 2 diabetes)Yes

If Rhode Island Medicaid says no, two cash programs to check.

No insurance needed.

  1. Strut Health$149 a month, with auto-refillcompounded semaglutideCheck price →You pick Weight Loss, then a five-minute online visit
  2. Shed$199 a month30% off first month with code Shed10compounded semaglutideCheck price →A health form first, then you choose your plan

Cheapest GLP-1 without insurance compares the three cash routes, and cheapest GLP-1 in Rhode Island prices each drug that ships there.

A clinical trial costs nothing, and nobody checks your income.

Prior-authorization criteria

These rules come from the state preferred drug list (PDL), the list of drugs Rhode Island Medicaid has agreed to pay for. Prior authorization means your doctor asks the plan to approve the drug before the pharmacy fills it. Nearly every state covers the diabetes path that way.

CriterionValue
How hard the approval isMedium
BMI threshold (weight-loss path)The state does not publish one. Ask your plan.
Comorbidity requiredNo
Last PDL update reviewedJuly 1, 2026

If the plan denies it, the appeal letter templates cover the reasons plans give and what to send back.

What Rhode Island Medicaid paid for GLP-1s

Rhode Island Medicaid reported 11,485 GLP-1 prescriptions to CMS in 2025's last quarter and paid pharmacies $12.2 million.

Counts Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda and Rybelsus, in fee-for-service and managed care, before rebates. CMS blanks its smallest rows, so the real figures are higher. Source: CMS State Drug Utilization Data.

What this means in practice

The cut is in the state budget the governor signed. Ask your doctor what happens to your prescription on October 1, and whether type 2 diabetes on your chart would keep you covered. If not, the cash-pay options below start around $149 a month.

Managed-care organizations in Rhode Island

Rhode Island Medicaid pays private health plans, called managed-care organizations or MCOs, to run its coverage. An MCO has to cover at least what the state list covers and can add rules of its own. Check your own plan's current rules before you send anything in.

  • Neighborhood Health Plan of Rhode Island
  • UnitedHealthcare Community Plan RI

Cash-pay alternatives if Medicaid does not cover you

If BMI threshold not met, the diabetes path applies for T2D.

If you end up paying cash, the GLP-1 cost guide has what each cash route costs, from the compounded floor to the manufacturer-direct brand prices. Federal law bars manufacturer savings cards for anyone on Medicaid.

If a supply gap rather than cost is blocking your refill, the GLP-1 shortage tracker shows which formulations the FDA lists as in shortage now. And if you are 65 or older and also have Medicare, the senior GLP-1 hub lays out the Medicare coverage paths for dual-eligible patients.

For the full cash-pay picture specific to Rhode Island, see the cheapest GLP-1 in Rhode Island guide.

6 GLP-1 clinical trials are recruiting in Rhode Island, and a study supplies its own study medication. Every site is listed on GLP-1 clinical trials in Rhode Island.

Rhode Island Medicaid GLP-1 FAQ

Does Rhode Island Medicaid cover Wegovy for weight loss?
It depends. Coverage of Wegovy for weight loss under Rhode Island Medicaid is limited and can vary by managed-care plan. Prior authorization is required. Check your specific plan's drug list. Last state review: 2026-07-01.
Does Rhode Island Medicaid cover Zepbound for weight loss?
It depends. Coverage of Zepbound for weight loss under Rhode Island Medicaid is limited and can vary by managed-care plan. Prior authorization is required. Check your specific plan's drug list. Last state review: 2026-07-01.
Does Rhode Island Medicaid cover Ozempic or Mounjaro for diabetes?
Yes. Rhode Island Medicaid covers Ozempic and Mounjaro for type 2 diabetes with prior authorization, usually after a trial of metformin. The diabetes pathway does not carry the BMI threshold that applies to the weight-loss pathway.
What if Rhode Island Medicaid does not cover my GLP-1?
If your GLP-1 is not covered, the routes left do not run through Medicaid. A clinical trial costs nothing and many pay you for your time. Nobody checks your income. Manufacturer savings cards are not a route here, because federal law bars them for anyone on Medicaid. The cheapest route left is cash-pay compounded semaglutide, a pharmacy-made version that is not FDA-approved and is not Wegovy or Ozempic. The prices checked October 12, 2026 are on the chart. If BMI threshold not met, the diabetes path applies for T2D. If you were denied, the appeal letter library has denial-specific templates.

Other state Medicaid pages

See the full 51-state coverage table for the side-by-side view across every US state.

How we built this page

Compiled from each state Medicaid's published preferred drug list, PA criteria and PDL committee minutes. State Medicaid programs are not federally required to cover obesity drugs; the diabetes indication is covered nearly everywhere with PA. State-level data is point-in-time and shifts each PDL cycle. Always verify with your state Medicaid plan before relying on this page.

Checked August 24, 2026. We check each state Medicaid PDL and PA criteria quarterly. If you have recently had a different experience with Rhode Island Medicaid, email hello@glpchart.com with the details and we will check it.

Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.